X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (103642) 103642
Publication (13434) 13434
Newsletter (2039) 2039
Book Chapter (869) 869
Book Review (812) 812
Conference Proceeding (205) 205
Dissertation (179) 179
Newspaper Article (132) 132
Magazine Article (85) 85
Book / eBook (65) 65
Web Resource (37) 37
Government Document (21) 21
Reference (18) 18
Data Set (15) 15
Trade Publication Article (13) 13
Streaming Video (11) 11
Paper (5) 5
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (75681) 75681
index medicus (41833) 41833
hematology (28894) 28894
oncology (28833) 28833
female (28466) 28466
male (28046) 28046
animals (26729) 26729
acute myeloid-leukemia (21760) 21760
adult (19877) 19877
middle aged (19145) 19145
mice (18113) 18113
cancer (17166) 17166
leukemia (15402) 15402
aged (13922) 13922
immunology (11432) 11432
adolescent (10277) 10277
research (10139) 10139
cell biology (9906) 9906
expression (9764) 9764
apoptosis (9327) 9327
acute myeloid leukemia (9160) 9160
leukemia, myeloid, acute - genetics (8210) 8210
chronic myeloid leukemia (7994) 7994
biochemistry & molecular biology (7936) 7936
prognosis (7919) 7919
chronic myeloid-leukemia (7739) 7739
leukemia, myeloid, acute - pathology (7618) 7618
child (7594) 7594
cell line, tumor (7255) 7255
transplantation (7073) 7073
mutation (6823) 6823
stem cells (6798) 6798
article (6769) 6769
chemotherapy (6581) 6581
gene expression (6499) 6499
analysis (6213) 6213
leukemia, myeloid, acute - drug therapy (6193) 6193
acute lymphoblastic-leukemia (6119) 6119
hemic and lymphatic diseases (6077) 6077
acute disease (6013) 6013
care and treatment (5976) 5976
genetic aspects (5752) 5752
chronic myelogenous leukemia (5706) 5706
cells (5621) 5621
health aspects (5618) 5618
cell line (5507) 5507
signal transduction (5504) 5504
treatment outcome (5429) 5429
flow cytometry (5387) 5387
acute myelogenous leukemia (5367) 5367
cells, cultured (5349) 5349
myeloid cells (5344) 5344
proteins (5320) 5320
differentiation (5216) 5216
bone marrow (4921) 4921
activation (4915) 4915
mice, inbred c57bl (4904) 4904
child, preschool (4882) 4882
medicine, research & experimental (4839) 4839
antineoplastic agents - therapeutic use (4823) 4823
aged, 80 and over (4624) 4624
tumor cells, cultured (4605) 4605
leukemia, myeloid - pathology (4567) 4567
leukemia, myeloid, acute - therapy (4543) 4543
hematopoietic stem cells (4392) 4392
apoptosis - drug effects (4339) 4339
therapy (4270) 4270
antineoplastic agents - pharmacology (4250) 4250
cell differentiation (4202) 4202
young adult (4193) 4193
dendritic cells (4120) 4120
abridged index medicus (3985) 3985
risk factors (3922) 3922
inflammation (3917) 3917
aml (3898) 3898
leukemia, myeloid, acute - metabolism (3891) 3891
genetics & heredity (3886) 3886
tumors (3885) 3885
myeloid leukemia (3869) 3869
pharmacology & pharmacy (3859) 3859
antineoplastic combined chemotherapy protocols - therapeutic use (3780) 3780
myeloid-leukemia (3690) 3690
leukemia, myeloid - genetics (3685) 3685
multidisciplinary sciences (3680) 3680
survival (3586) 3586
cell proliferation (3575) 3575
gene (3570) 3570
research article (3532) 3532
infant (3517) 3517
in-vivo (3447) 3447
gene-expression (3430) 3430
hematology, oncology and palliative medicine (3426) 3426
colony-stimulating factor (3404) 3404
hematopoietic stem cell transplantation (3401) 3401
immunotherapy (3395) 3395
mice, knockout (3381) 3381
transplantation, homologous (3366) 3366
physiological aspects (3361) 3361
bone marrow - pathology (3261) 3261
genes (3243) 3243
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (27) 27
Online Resources - Online (23) 23
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Credit Valley Hospital - Stacks (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Reference (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Reference (1) 1
UTL at Downsview - May be requested (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (101603) 101603
Chinese (1163) 1163
Japanese (906) 906
German (782) 782
French (691) 691
Russian (629) 629
Spanish (254) 254
Polish (211) 211
Italian (108) 108
Korean (92) 92
Portuguese (51) 51
Czech (46) 46
Hungarian (35) 35
Croatian (18) 18
Danish (18) 18
Turkish (17) 17
Serbian (15) 15
Dutch (14) 14
Swedish (13) 13
Norwegian (11) 11
Romanian (11) 11
Slovak (10) 10
Persian (9) 9
Ukrainian (9) 9
Bulgarian (6) 6
Slovenian (5) 5
Arabic (3) 3
Bosnian (3) 3
Finnish (3) 3
Afrikaans (1) 1
Greek (1) 1
Hebrew (1) 1
Welsh (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Clinical Investigation, ISSN 0021-9738, 05/2009, Volume 119, Issue 5, pp. 1109 - 1123
Imatinib mesylate (IM), a potent inhibitor of the BCR/ABL tyrosine kinase, has become standard first-line therapy for patients with chronic myeloid leukemia... 
CHRONIC MYELOGENOUS LEUKEMIA | MEDICINE, RESEARCH & EXPERIMENTAL | MALIGNANT GLIOMA-CELLS | BLAST CRISIS | CLINICAL RESISTANCE | BCR-ABL MUTATIONS | ENDOPLASMIC-RETICULUM | CYTOCHROME-C RELEASE | CASPASE ACTIVATION | IMATINIB RESISTANCE | CHRONIC MYELOID-LEUKEMIA | Transcription Factor CHOP - genetics | Neoplastic Stem Cells - cytology | Gene Expression - drug effects | Calcium - metabolism | Gene Expression - genetics | Microtubule-Associated Proteins - metabolism | Neoplastic Stem Cells - drug effects | Humans | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - drug therapy | Endoplasmic Reticulum - metabolism | Antineoplastic Agents - therapeutic use | Autophagy - physiology | Thiazoles - therapeutic use | Autophagy - drug effects | Chloroquine - pharmacology | Neoplastic Stem Cells - metabolism | RNA Interference | Endoplasmic Reticulum - drug effects | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - pathology | Macrolides - pharmacology | Antineoplastic Agents - pharmacology | Cell Death - drug effects | Dasatinib | Chloroquine - therapeutic use | Piperazines - therapeutic use | Pyrimidines - pharmacology | Imatinib Mesylate | Piperazines - pharmacology | Mice, Inbred C3H | Xenograft Model Antitumor Assays | Fusion Proteins, bcr-abl - genetics | Animals | Cell Death - physiology | Protein Kinase Inhibitors - therapeutic use | Pyrimidines - therapeutic use | Fusion Proteins, bcr-abl - antagonists & inhibitors | Cell Line, Tumor | Leukemia, Myelogenous, Chronic, BCR-ABL Positive - metabolism | Mice | Protein Kinase Inhibitors - pharmacology | Thiazoles - pharmacology | Benzamides | Macrolides - therapeutic use | Protein-Tyrosine Kinases - antagonists & inhibitors | Causes of | Physiological aspects | Genetic aspects | Chronic myeloid leukemia | Research | Drug therapy | Phagocytosis
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2017, Volume 23, Issue 3, pp. 452 - 458
Journal Article
Journal Article
Pediatric Blood & Cancer, ISSN 1545-5009, 03/2015, Volume 62, Issue 3, pp. 522 - 528
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e51845
Journal Article
Transplantation, ISSN 0041-1337, 08/2016, Volume 100, Issue 8, pp. 1732 - 1739
BACKGROUNDThe impact of antithymocyte globulin (ATG) in the setting of a myeloablative conditioning transplantation remains controversial, especially when... 
SURGERY | PROGNOSTIC-FACTORS | ANTITHYMOCYTE GLOBULIN | RANDOMIZED-TRIAL | RISK | IMMUNOLOGY | VERSUS-HOST-DISEASE | TRANSPLANTATION | PROPHYLAXIS | HEMATOLOGICAL MALIGNANCIES | MYELOID-LEUKEMIA | OUTCOMES | MYELODYSPLASTIC SYNDROMES | Recurrence | Whole-Body Irradiation | Peripheral Blood Stem Cell Transplantation - methods | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Bone Marrow Transplantation - methods | Graft vs Host Disease - immunology | Transplantation Conditioning - mortality | Young Adult | Time Factors | Transplantation Conditioning - methods | Antilymphocyte Serum - adverse effects | Histocompatibility Testing | Risk Factors | HLA Antigens - immunology | Peripheral Blood Stem Cell Transplantation - mortality | Leukemia, Myeloid, Acute - mortality | Bone Marrow Transplantation - mortality | Adolescent | Myelodysplastic Syndromes - mortality | Chronic Disease | Histocompatibility | Myeloablative Agonists - therapeutic use | Multivariate Analysis | Peripheral Blood Stem Cell Transplantation - adverse effects | Leukemia, Myeloid, Acute - immunology | Cyclophosphamide - therapeutic use | Antilymphocyte Serum - therapeutic use | Adult | Dose Fractionation | Female | Leukemia, Myeloid, Acute - surgery | Transplantation Conditioning - adverse effects | Unrelated Donors | Retrospective Studies | France | Myelodysplastic Syndromes - surgery | Busulfan - therapeutic use | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Chi-Square Distribution | Disease-Free Survival | Myelodysplastic Syndromes - diagnosis | Leukemia, Myeloid, Acute - diagnosis | Graft vs Host Disease - prevention & control | Immunosuppressive Agents - adverse effects | Myelodysplastic Syndromes - immunology
Journal Article